Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome
- 30 April 1993
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 100 (1), 55-64
- https://doi.org/10.1016/0021-9150(93)90067-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Delayed clearance of postprandial chylomicrons and their remnants in the hypoalphalipoproteinemia and mild hypertriglyceridemia syndrome.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Familial lipoprotein disorders in patients with premature coronary artery disease.Circulation, 1992
- Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteinsAtherosclerosis, 1992
- Plasma triglyceride and coronary heart disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Postprandial lipemia, fenofibrate and coronary artery diseaseAtherosclerosis, 1990
- Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitorMetabolism, 1990
- Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemiaEuropean Journal of Clinical Investigation, 1989
- PLASMA TRIGLYCERIDE AS A RISK FACTOR FOR CORONARY HEART DISEASEAmerican Journal of Epidemiology, 1989
- Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.Journal of Clinical Investigation, 1987
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986